Reproductive BioMedicine Online
Volume 21, Issue 3 , Pages 338-343, September 2010

Treatment with oxytocin antagonists before embryo transfer may increase implantation rates after IVF

Dr. Zekai Tahir Burak Woman’s Health Education and Research Hospital, Assisted Reproduction Unit, Ankara, Turkey

Received 1 November 2009; received in revised form 12 March 2010; accepted 7 April 2010. published online 20 July 2010.

Declaration: The authors report no financial or commercial conflicts of interest.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr Ozlem Moraloglu obtained her MD degree in 1992 from the Medical School, University of Ankara, Turkey. Since 1997 she has specialized in obstetric gynaecology. Dr Moraloglu is currently employed at Dr Zekai Tahir Burak Women’s Hospital in the Reproductive Endocrinology and IVF Department. Her research interests focus on assisted reproduction treatments and reproductive endocrinology. She has published 14 scientific articles in national and international journals.

PII: S1472-6483(10)00218-X

doi:10.1016/j.rbmo.2010.04.009

Reproductive BioMedicine Online
Volume 21, Issue 3 , Pages 338-343, September 2010